RxDoctor Payments Data

Charles Simmons, MD

Interventional Pain Medicine · Annapolis, MDNPI 1255451183

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.4%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 19.9%. Among interventional pain medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,638in general payments, 2019–2025

Across 1,321 payments — averaging $46.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$12K
  • Vertos Medical, Inc.$12K
  • Medtronic$9K
  • Nevro Corp.$5K
  • Boston Scientific$5K
  • Stryker$4K
  • plus $14K from 42 others
$10,906in research payments, 2019–2025

Across 11 payments — averaging $991.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Si-bone, Inc.$11K

What the payments were for

  • Consulting fees$17,44028%
  • Speaking & faculty fees$7,95513%
  • Travel & lodging$5,1618%
  • Food & beverage$31,07850%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,638 in reported general payments places this provider in the 90th percentile of 56 interventional pain medicine providers in Maryland.

See all interventional pain medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$432,749
Medicare patients
606
Services billed
3,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl31$24,217
Oxycodone Hcl256$4,218
Lidocaine20$1,545
Gabapentin54$949
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav75$750
Cyclobenzaprine Hcl33$734
Pregabalin41$703
Morphine Sulfate ErMorphine Sulfate34$663
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen57$597
Hydromorphone Hcl29$547
Morphine Sulfate15$415
Clindamycin Hcl41$342
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$249
Methylprednisolone33$246
Ibuprofen16$232

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →